ニコチンポーチの使用と米国成人の禁煙意思
Sunday Azagba1, Galappaththige S R de Silva2, Todd Ebling2
1College of Nursing, Pennsylvania State University, University Park, PA, 16802, USA. spa5695@psu.edu.
Background:
As traditional tobacco use has declined, the market for novel nicotine products, particularly nicotine pouches, has increased in recent years. This study examines factors associated with nicotine pouch use and their relationship with intentions to quit cigarette smoking.
Methods:
This study utilized nationally representative survey data from the 2022/2023 Tobacco Use Supplement to the Current Population Survey. Multivariable logistic regressions were performed to examine sociodemographic and behavioral factors associated with current nicotine pouch use. Additionally, we assessed whether the use of nicotine pouches was associated with intentions to quit cigarette smoking among current cigarette smokers.
Results:
Current nicotine pouch use was reported by approximately 0.5% of adults, with a higher prevalence (1.2%) in current cigarette smokers. Current nicotine pouch users were significantly more likely to be male, younger, non-Hispanic White, and to use other tobacco products. Among current cigarette smokers, those using nicotine pouches had significantly higher odds of intending to quit smoking within the next 6 months (OR = 1.78, 95% CI = 1.12 - 2.83) and within the next 30 days (OR = 2.09, 95% CI = 1.24 - 3.52).
Conclusion:
Nicotine pouch use is more prevalent among younger, male, non-Hispanic White, and smoking adults. A positive association was found between nicotine pouch use and intentions to quit smoking among current smokers. While popular in specific groups and associated with cigarette quit intentions, these products present both potential public health benefits and risks that warrant continued investigation.
さらに関連する動画
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
関連する概念動画
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Stress Prevention and Stress Management Techniques IV
Statistical Methods for Analyzing Epidemiological Data
